Pinnacle Associates’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$303K Sell
5,195
-6
-0.1% -$335 ﹤0.01% 797
2026
Q2
$283K Sell
5,201
-394
-7% -$19.2K ﹤0.01% 834
2026
Q1
$240K Sell
5,595
-1,174
-17% -$50.5K ﹤0.01% 866
2025
Q4
$297K Buy
+6,769
New +$280K ﹤0.01% 788

Other funds holding EXEL

Pinnacle Associates's EXEL Position: Q3 2026 in Review

Pinnacle Associates reduced its Exelixis (EXEL) stake by 0.12% in Q3 2026, selling an estimated $335 and leaving 5,195 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

Pinnacle Associates first reported a position in EXEL in Q4 2025 and has held it in 4 quarters since. 251 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Pinnacle Associates held 5,195 shares of Exelixis worth $303K as of Q3 2026.
  • Pinnacle Associates sold 6 Exelixis shares in Q3 2026, an estimated $335.
  • Exelixis made up ﹤0.01% of Pinnacle Associates's portfolio in Q3 2026, its #797 holding.
  • Pinnacle Associates first reported a position in Exelixis in Q4 2025 and has held it in 4 quarters since.
  • 251 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.